NBI raids skin care firm not licensed by FDA | Inquirer News
P1M WORTH OF COSMETIC PRODUCTS SEIZED

NBI raids skin care firm not licensed by FDA

By: - Reporter / @NikkaINQ
/ 04:02 AM November 05, 2019

USE AT YOUR OWN RISK Angel’s Skin Care products are sold in skin clinics and online shops, says the NBI. Photo courtesy of the NBI

Agents of the National Bureau of Investigation have seized over P1 million worth of whitening soap and cosmetic products that reportedly did not have the necessary permits from the Food and Drug Administration (FDA).

Kristine dela Cruz, NBI Special Action Unit executive officer, said that the products manufactured by Angel’s Skin Care were being distributed to several skin clinics and online shops.

Article continues after this advertisement

Josephine Tuan, the alleged owner of the company, was not around when its office and factory were raided simultaneously last week. She faces charges of violating the Food and Drug Administration Act of 2009.

FEATURED STORIES

Among the firm’s products were the Professional Skin Care Formula toners and soaps of different varieties, including glutathione, kojic acid and oatmeal.

Soaps, peeling lotions

Article continues after this advertisement

Other products seized from the company office on Ragang Street in Barangay Manresa, Quezon City, were unbranded soaps and peeling lotions.

Article continues after this advertisement

There were also cosmetic products under the brand name Skin Expert Secrets featuring a rejuvenating facial set.

Article continues after this advertisement

The NBI said that these products were not registered with the FDA which had also not issued a license to operate to the company.

NBI operatives who raided the company’s manufacturing plant on Simoun Street in Barangay La Loma, Quezon City, found out that the workers were not using the proper gear in the making and handling of cosmetic products.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: FDA

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.